O	0	7	Effects
O	8	10	of
B-intervention	11	19	exercise
O	20	22	on
B-condition	23	28	sleep
O	29	37	problems
O	38	40	in
B-eligibility	41	47	breast
I-eligibility	48	54	cancer
I-eligibility	55	63	patients
I-eligibility	64	73	receiving
I-eligibility	74	86	radiotherapy
O	86	87	:
O	88	89	a
O	90	100	randomized
O	101	109	clinical
O	110	115	trial
O	115	116	.

O	117	122	Sleep
O	123	131	problems
O	132	142	frequently
O	143	149	affect
O	150	156	breast
O	157	163	cancer
O	164	172	patients
O	173	179	during
O	180	183	and
O	184	189	after
O	190	199	treatment
O	200	203	and
O	204	210	reduce
O	211	216	their
O	217	224	quality
O	225	227	of
O	228	232	life
O	232	233	.

O	234	243	Treatment
O	244	254	strategies
O	255	258	are
O	259	265	mostly
O	266	273	unknown
O	273	274	.

O	275	279	Thus
O	279	280	,
O	281	283	we
O	284	292	assessed
O	293	299	within
O	300	301	a
O	302	312	randomized
O	313	323	controlled
O	324	329	trial
O	330	337	whether
O	338	339	a
O	340	342	12
O	342	343	-
O	343	347	week
O	348	356	exercise
O	357	364	program
O	365	373	starting
O	374	378	with
O	379	382	the
O	383	395	radiotherapy
O	396	406	influences
O	407	412	sleep
O	413	425	trajectories
O	425	426	.

O	427	432	Sleep
O	433	440	quality
O	441	444	and
O	445	453	problems
O	454	458	were
O	459	467	assessed
O	468	471	via
O	472	476	self
O	476	477	-
O	477	483	report
O	484	486	in
B-total-participants	487	490	160
O	491	497	breast
O	498	504	cancer
O	505	513	patients
O	514	520	before
O	520	521	,
O	522	528	during
O	528	529	,
O	530	533	and
O	534	535	2
O	535	536	,
O	537	538	6
O	538	539	,
O	540	543	and
O	544	546	12
O	547	553	months
O	554	559	after
O	560	573	participation
O	574	576	in
O	577	578	a
O	579	584	trial
O	585	598	investigating
O	599	609	resistance
O	610	618	exercise
O	619	625	versus
O	626	627	a
B-control	628	638	relaxation
I-control	639	646	control
I-control	647	652	group
O	653	664	concomitant
O	665	669	with
O	670	682	radiotherapy
O	682	683	.

O	684	686	As
O	687	697	additional
O	698	708	comparison
O	709	714	group
O	714	715	,
O	716	718	25
O	719	722	age
O	722	723	-
O	723	730	matched
O	731	738	healthy
O	739	744	women
O	745	754	exercised
O	755	758	and
O	759	767	followed
O	768	777	identical
O	778	783	study
O	784	794	procedures
O	794	795	.

O	796	803	Ordinal
O	804	812	logistic
O	813	823	regression
O	824	832	analyses
O	833	837	were
O	838	842	used
O	842	843	.

O	844	847	The
O	848	856	exercise
O	857	869	intervention
O	870	883	significantly
O	884	893	decreased
B-outcome	894	899	sleep
I-outcome	900	908	problems
O	909	917	compared
O	918	920	to
O	921	924	the
O	925	935	relaxation
O	936	943	control
O	944	949	group
O	950	951	(
O	951	956	scale
O	956	957	:
O	958	959	0
O	959	960	-
O	960	963	100
O	963	964	,
O	965	969	with
O	970	977	between
O	977	978	-
O	978	983	group
O	984	988	mean
O	989	1000	differences
O	1001	1003	of
O	1004	1005	-
O	1005	1007	10
O	1007	1008	.
O	1008	1009	2
O	1010	1011	(
O	1011	1012	p
O	1013	1014	=
O	1015	1016	0
O	1016	1017	.
O	1017	1019	03
O	1019	1020	)
O	1021	1025	from
O	1026	1034	baseline
O	1035	1037	to
O	1038	1041	the
O	1042	1045	end
O	1046	1048	of
O	1049	1061	radiotherapy
O	1062	1065	and
O	1066	1067	-
O	1067	1069	10
O	1069	1070	.
O	1070	1071	9
O	1072	1073	(
O	1073	1074	p
O	1075	1076	=
O	1077	1078	0
O	1078	1079	.
O	1079	1082	005
O	1082	1083	)
O	1084	1086	to
O	1087	1090	the
O	1091	1094	end
O	1095	1097	of
O	1098	1101	the
O	1102	1114	intervention
O	1114	1115	)
O	1115	1116	,
O	1117	1121	with
O	1122	1127	sleep
O	1128	1136	problems
O	1137	1147	decreasing
O	1148	1150	in
O	1151	1154	the
O	1155	1163	exercise
O	1164	1169	group
O	1170	1173	and
O	1174	1184	increasing
O	1185	1187	in
O	1188	1191	the
O	1192	1199	control
O	1200	1205	group
O	1205	1206	.

O	1207	1209	At
O	1210	1212	12
O	1213	1219	months
O	1219	1220	,
O	1221	1232	differences
O	1233	1237	were
O	1238	1243	still
O	1244	1252	observed
O	1253	1256	but
O	1257	1270	statistically
O	1271	1274	non
O	1274	1275	-
O	1275	1286	significant
O	1287	1288	(
O	1288	1292	mean
O	1293	1303	difference
O	1304	1305	=
O	1306	1307	-
O	1307	1308	5
O	1308	1309	.
O	1309	1310	9
O	1310	1311	,
O	1312	1313	p
O	1314	1315	=
O	1316	1317	0
O	1317	1318	.
O	1318	1320	20
O	1320	1321	)
O	1321	1322	.

O	1323	1330	Further
O	1331	1341	adjustment
O	1342	1345	for
O	1346	1355	potential
O	1356	1367	confounders
O	1368	1371	did
O	1372	1375	not
O	1376	1382	change
O	1383	1386	the
O	1387	1394	results
O	1394	1395	.

O	1396	1403	Several
O	1404	1416	determinants
O	1417	1419	of
B-outcome	1420	1425	sleep
I-outcome	1426	1434	problems
O	1435	1437	at
O	1438	1446	baseline
O	1447	1451	were
O	1452	1462	identified
O	1462	1463	,
O	1464	1465	e
O	1465	1466	.
O	1466	1467	g
O	1467	1468	.
O	1468	1469	,
O	1470	1478	previous
O	1479	1491	chemotherapy
O	1492	1495	and
O	1496	1502	higher
O	1503	1507	body
O	1508	1512	mass
O	1513	1518	index
O	1518	1519	.

O	1520	1523	Our
O	1524	1534	randomized
O	1535	1543	exercise
O	1544	1556	intervention
O	1557	1562	trial
O	1563	1572	confirmed
O	1573	1580	results
O	1581	1585	from
O	1586	1593	earlier
O	1594	1597	but
O	1598	1604	mostly
O	1605	1612	smaller
O	1613	1620	studies
O	1621	1625	that
O	1626	1638	radiotherapy
O	1639	1649	aggravates
O	1650	1655	sleep
O	1656	1664	problems
O	1665	1667	in
O	1668	1674	breast
O	1675	1681	cancer
O	1682	1690	patients
O	1691	1694	and
O	1695	1699	that
O	1700	1708	exercise
O	1709	1712	can
O	1713	1723	ameliorate
O	1724	1729	these
O	1730	1737	effects
O	1737	1738	.

O	1739	1750	Considering
O	1751	1755	that
O	1756	1761	sleep
O	1762	1769	quality
O	1770	1773	can
O	1774	1776	be
O	1777	1778	a
O	1779	1784	major
O	1785	1794	predictor
O	1795	1797	of
O	1798	1805	quality
O	1806	1808	of
O	1809	1813	life
O	1813	1814	,
O	1815	1818	our
O	1819	1827	findings
O	1828	1831	are
O	1832	1834	of
O	1835	1846	substantial
O	1847	1857	importance
O	1858	1860	to
O	1861	1865	many
O	1866	1872	breast
O	1873	1879	cancer
O	1880	1888	patients
O	1888	1889	.
